Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study. [electronic resource]
Producer: 19960709Description: 479-89 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chemotherapy, Cancer, Regional Perfusion
- Extremities
- Female
- Humans
- Interferon-gamma -- administration & dosage
- Male
- Melanoma -- therapy
- Melphalan -- administration & dosage
- Middle Aged
- Recombinant Proteins -- administration & dosage
- Soft Tissue Neoplasms -- therapy
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.